Creador Acquires 7% Stake in India's La Renon Healthcare Amid Strong Growth Momentum
ByAinvest
Monday, Dec 8, 2025 2:55 am ET1min read
Creador, a private equity firm, has acquired a 7% stake in India-based pharmaceutical firm La Renon Healthcare from its promoter and an existing investor. La Renon's promoter family will continue to hold a controlling stake, while Peak XV Partners will remain a shareholder. Creador said the transaction marks its focus on partnering with high-quality healthcare companies. La Renon reported a 25% compounded annual growth rate in revenue and a 30% CAGR in earnings before interest, taxes, depreciation, and amortization over the last decade.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet